USD 3.79
(-2.07%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 125.34 Million USD | -18.44% |
2022 | 153.68 Million USD | 18.9% |
2021 | 129.24 Million USD | 19.52% |
2020 | 108.14 Million USD | 24.61% |
2019 | 86.78 Million USD | 1.88% |
2018 | 85.18 Million USD | 19.61% |
2017 | 71.21 Million USD | 5.1% |
2016 | 67.76 Million USD | -6.19% |
2015 | 72.23 Million USD | -6.1% |
2014 | 76.92 Million USD | -2.69% |
2013 | 79.05 Million USD | 10.04% |
2012 | 71.84 Million USD | 17.55% |
2011 | 61.11 Million USD | 20.51% |
2010 | 50.71 Million USD | -4.12% |
2009 | 52.89 Million USD | -7.94% |
2008 | 57.45 Million USD | 11.57% |
2007 | 51.5 Million USD | 35.76% |
2006 | 37.93 Million USD | 12.17% |
2005 | 33.81 Million USD | 1.8% |
2004 | 33.22 Million USD | 29.39% |
2003 | 25.67 Million USD | 13.3% |
2002 | 22.66 Million USD | -6.05% |
2001 | 24.12 Million USD | -8.31% |
2000 | 26.3 Million USD | 152.96% |
1999 | 10.4 Million USD | 15.56% |
1998 | 9 Million USD | -22.41% |
1997 | 11.6 Million USD | -25.64% |
1996 | 15.6 Million USD | -20.0% |
1995 | 19.5 Million USD | 29.14% |
1994 | 15.1 Million USD | 0.67% |
1993 | 15 Million USD | 59.57% |
1992 | 9.4 Million USD | 34.29% |
1991 | 7 Million USD | 42.86% |
1990 | 4.9 Million USD | 188.24% |
1989 | 1.7 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 27.64 Million USD | -0.91% |
2024 Q2 | 25.61 Million USD | -7.36% |
2023 FY | 125.34 Million USD | -18.44% |
2023 Q4 | 27.9 Million USD | -16.58% |
2023 Q2 | 32.62 Million USD | -19.28% |
2023 Q1 | 40.41 Million USD | 11.31% |
2023 Q3 | 33.44 Million USD | 2.53% |
2022 Q4 | 36.3 Million USD | -6.33% |
2022 Q1 | 40.28 Million USD | 10.48% |
2022 Q2 | 38.33 Million USD | -4.85% |
2022 FY | 153.68 Million USD | 18.9% |
2022 Q3 | 38.75 Million USD | 1.11% |
2021 Q2 | 29.09 Million USD | 1.34% |
2021 Q3 | 34.98 Million USD | 20.23% |
2021 Q1 | 28.71 Million USD | -9.68% |
2021 Q4 | 36.46 Million USD | 4.24% |
2021 FY | 129.24 Million USD | 19.52% |
2020 Q1 | 23.06 Million USD | -9.81% |
2020 FY | 108.14 Million USD | 24.61% |
2020 Q2 | 27.32 Million USD | 18.46% |
2020 Q3 | 25.96 Million USD | -4.98% |
2020 Q4 | 31.78 Million USD | 22.43% |
2019 FY | 86.78 Million USD | 1.88% |
2019 Q4 | 25.57 Million USD | 21.04% |
2019 Q1 | 20.59 Million USD | -7.2% |
2019 Q3 | 21.13 Million USD | 8.45% |
2019 Q2 | 19.48 Million USD | -5.4% |
2018 Q2 | 20.33 Million USD | -18.54% |
2018 FY | 85.18 Million USD | 19.61% |
2018 Q3 | 17.68 Million USD | -13.03% |
2018 Q4 | 22.19 Million USD | 25.47% |
2018 Q1 | 24.96 Million USD | 35.95% |
2017 Q2 | 18.59 Million USD | 9.75% |
2017 FY | 71.21 Million USD | 5.1% |
2017 Q4 | 18.36 Million USD | 6.0% |
2017 Q3 | 17.32 Million USD | -6.8% |
2017 Q1 | 16.93 Million USD | 0.34% |
2016 Q1 | 17.61 Million USD | -1.26% |
2016 Q2 | 16.73 Million USD | -4.98% |
2016 FY | 67.76 Million USD | -6.19% |
2016 Q3 | 16.53 Million USD | -1.22% |
2016 Q4 | 16.88 Million USD | 2.12% |
2015 FY | 72.23 Million USD | -6.1% |
2015 Q4 | 17.83 Million USD | -6.77% |
2015 Q3 | 19.13 Million USD | 6.44% |
2015 Q1 | 17.28 Million USD | -15.83% |
2015 Q2 | 17.97 Million USD | 3.97% |
2014 FY | 76.92 Million USD | -2.69% |
2014 Q1 | 19.54 Million USD | 0.93% |
2014 Q4 | 20.54 Million USD | 15.24% |
2014 Q3 | 17.82 Million USD | -6.29% |
2014 Q2 | 19.01 Million USD | -2.69% |
2013 Q4 | 19.36 Million USD | 13.96% |
2013 Q3 | 16.99 Million USD | -15.35% |
2013 Q2 | 20.07 Million USD | -11.24% |
2013 FY | 79.05 Million USD | 10.04% |
2013 Q1 | 22.61 Million USD | 16.58% |
2012 Q4 | 19.4 Million USD | 15.37% |
2012 Q3 | 16.81 Million USD | -7.8% |
2012 Q2 | 18.23 Million USD | 4.92% |
2012 Q1 | 17.38 Million USD | 16.86% |
2012 FY | 71.84 Million USD | 17.55% |
2011 Q3 | 17.79 Million USD | 21.74% |
2011 FY | 61.11 Million USD | 20.51% |
2011 Q4 | 14.87 Million USD | -16.42% |
2011 Q2 | 14.62 Million USD | 5.79% |
2011 Q1 | 13.81 Million USD | 7.17% |
2010 Q4 | 12.89 Million USD | 11.89% |
2010 FY | 50.71 Million USD | -4.12% |
2010 Q1 | 13.58 Million USD | -13.93% |
2010 Q2 | 12.71 Million USD | -6.38% |
2010 Q3 | 11.52 Million USD | -9.34% |
2009 Q1 | 12.83 Million USD | -18.77% |
2009 FY | 52.89 Million USD | -7.94% |
2009 Q2 | 12.15 Million USD | -5.27% |
2009 Q4 | 15.77 Million USD | 30.1% |
2009 Q3 | 12.12 Million USD | -0.23% |
2008 Q3 | 13.05 Million USD | -12.68% |
2008 FY | 57.45 Million USD | 11.57% |
2008 Q1 | 13.65 Million USD | 5.27% |
2008 Q2 | 14.95 Million USD | 9.5% |
2008 Q4 | 15.79 Million USD | 21.0% |
2007 Q1 | 11.92 Million USD | 5.56% |
2007 FY | 51.5 Million USD | 35.76% |
2007 Q2 | 12.87 Million USD | 7.97% |
2007 Q4 | 12.97 Million USD | -5.5% |
2007 Q3 | 13.72 Million USD | 6.58% |
2006 Q4 | 11.29 Million USD | 28.48% |
2006 FY | 37.93 Million USD | 12.17% |
2006 Q2 | 9.12 Million USD | 4.77% |
2006 Q3 | 8.79 Million USD | -3.66% |
2006 Q1 | 8.71 Million USD | 0.75% |
2005 Q2 | 8.49 Million USD | 3.1% |
2005 FY | 33.81 Million USD | 1.8% |
2005 Q4 | 8.64 Million USD | 2.57% |
2005 Q3 | 8.43 Million USD | -0.79% |
2005 Q1 | 8.24 Million USD | -8.44% |
2004 FY | 33.22 Million USD | 29.39% |
2004 Q4 | 9 Million USD | 0.75% |
2004 Q3 | 8.93 Million USD | 15.43% |
2004 Q2 | 7.74 Million USD | 2.61% |
2004 Q1 | 7.54 Million USD | 10.24% |
2003 Q2 | 6.36 Million USD | 3.32% |
2003 Q1 | 6.15 Million USD | 24.94% |
2003 Q3 | 6.31 Million USD | -0.68% |
2003 Q4 | 6.84 Million USD | 8.34% |
2003 FY | 25.67 Million USD | 13.3% |
2002 FY | 22.66 Million USD | -6.05% |
2002 Q4 | 4.92 Million USD | -4.49% |
2002 Q2 | 6.08 Million USD | -6.29% |
2002 Q1 | 6.49 Million USD | 2.22% |
2002 Q3 | 5.15 Million USD | -15.22% |
2001 Q4 | 6.35 Million USD | 10.71% |
2001 Q1 | 5.49 Million USD | -30.72% |
2001 Q3 | 5.73 Million USD | -5.82% |
2001 Q2 | 6.09 Million USD | 10.9% |
2001 FY | 24.12 Million USD | -8.31% |
2000 FY | 26.3 Million USD | 152.96% |
2000 Q4 | 7.92 Million USD | 9.85% |
2000 Q3 | 7.21 Million USD | 161.6% |
2000 Q2 | 2.75 Million USD | 4.71% |
2000 Q1 | 2.63 Million USD | 37.13% |
1999 FY | 10.4 Million USD | 15.56% |
1999 Q4 | 1.92 Million USD | -35.96% |
1999 Q3 | 3 Million USD | 7.14% |
1999 Q2 | 2.8 Million USD | 21.74% |
1999 Q1 | 2.3 Million USD | -4.17% |
1998 Q3 | 2.3 Million USD | -4.17% |
1998 FY | 9 Million USD | -22.41% |
1998 Q1 | 2.1 Million USD | -4.55% |
1998 Q2 | 2.4 Million USD | 14.29% |
1998 Q4 | 2.4 Million USD | 4.35% |
1997 FY | 11.6 Million USD | -25.64% |
1997 Q4 | 2.2 Million USD | 344.44% |
1997 Q3 | -900 Thousand USD | -119.57% |
1997 Q2 | 4.6 Million USD | 15.0% |
1997 Q1 | 4 Million USD | -11.11% |
1996 FY | 15.6 Million USD | -20.0% |
1996 Q4 | 4.5 Million USD | -32.84% |
1996 Q3 | 6.7 Million USD | 139.29% |
1996 Q2 | 2.8 Million USD | -12.5% |
1996 Q1 | 3.2 Million USD | 6.67% |
1995 Q3 | 5.5 Million USD | 14.58% |
1995 Q2 | 4.8 Million USD | -2.04% |
1995 Q1 | 4.9 Million USD | 16.67% |
1995 FY | 19.5 Million USD | 29.14% |
1995 Q4 | 3 Million USD | -45.45% |
1994 FY | 15.1 Million USD | 0.67% |
1994 Q4 | 4.2 Million USD | 0.0% |
1994 Q3 | 4.2 Million USD | 10.53% |
1994 Q2 | 3.8 Million USD | 2.7% |
1994 Q1 | 3.7 Million USD | 8.82% |
1993 Q1 | 3.6 Million USD | 5.88% |
1993 FY | 15 Million USD | 59.57% |
1993 Q2 | 3.8 Million USD | 5.56% |
1993 Q3 | 4.2 Million USD | 10.53% |
1993 Q4 | 3.4 Million USD | -19.05% |
1992 Q4 | 3.4 Million USD | 9.68% |
1992 Q2 | 2.3 Million USD | 15.0% |
1992 Q3 | 3.1 Million USD | 34.78% |
1992 FY | 9.4 Million USD | 34.29% |
1992 Q1 | 2 Million USD | -4.76% |
1991 FY | 7 Million USD | 42.86% |
1991 Q1 | 1.7 Million USD | 21.43% |
1991 Q2 | 1.8 Million USD | 5.88% |
1991 Q3 | 2.1 Million USD | 16.67% |
1991 Q4 | 2.1 Million USD | 0.0% |
1990 Q3 | 800 Thousand USD | -46.67% |
1990 FY | 4.9 Million USD | 188.24% |
1990 Q1 | 1.3 Million USD | 18.18% |
1990 Q2 | 1.5 Million USD | 15.38% |
1990 Q4 | 1.4 Million USD | 75.0% |
1989 Q2 | 1.2 Million USD | 0.0% |
1989 FY | 1.7 Million USD | 0.0% |
1989 Q1 | - USD | -100.0% |
1989 Q4 | 1.1 Million USD | 155.0% |
1989 Q3 | -2 Million USD | -266.67% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Akoya Biosciences, Inc. | 104.27 Million USD | -20.209% |
AngioDynamics, Inc. | 252.41 Million USD | 50.343% |
AtriCure, Inc. | 327.05 Million USD | 61.675% |
Avinger, Inc. | 18.63 Million USD | -572.508% |
Azenta, Inc. | 336.26 Million USD | 62.725% |
BioLife Solutions, Inc. | 117.57 Million USD | -6.604% |
The Cooper Companies, Inc. | 1.82 Billion USD | 93.131% |
Daxor Corporation | 1.28 Million USD | -9688.405% |
Ekso Bionics Holdings, Inc. | 24.19 Million USD | -418.135% |
Femasys Inc. | 15.2 Million USD | -724.601% |
GlucoTrack, Inc. | 7.1 Million USD | -1664.386% |
Harvard Bioscience, Inc. | 58.58 Million USD | -113.964% |
Hologic, Inc. | 1.34 Billion USD | 90.682% |
ICU Medical, Inc. | 717.04 Million USD | 82.52% |
Intuitive Surgical, Inc. | 2.96 Billion USD | 95.769% |
KORU Medical Systems, Inc. | 26.1 Million USD | -380.093% |
LeMaitre Vascular, Inc. | 90.33 Million USD | -38.749% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 105139.01% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 105139.01% |
Masimo Corporation | 867 Million USD | 85.543% |
Microbot Medical Inc. | 9.85 Million USD | -1171.862% |
Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -580.465% |
Merit Medical Systems, Inc. | 459.92 Million USD | 72.747% |
Nephros, Inc. | 9.78 Million USD | -1181.092% |
NovoCure Limited | 613.92 Million USD | 79.584% |
NEXGEL, Inc. | 4.09 Million USD | -2960.107% |
NEXGEL, Inc. | 4.09 Million USD | -2960.107% |
Singular Genomics Systems, Inc. | 102.24 Million USD | -22.592% |
Pro-Dex, Inc. | 7.37 Million USD | -1598.861% |
Pulse Biosciences, Inc. | 43.57 Million USD | -187.653% |
Predictive Oncology Inc. | 15.22 Million USD | -723.019% |
Precision Optics Corporation, Inc. | 8.52 Million USD | -1370.786% |
QuidelOrtho Corporation | 1.35 Billion USD | 90.752% |
Repligen Corporation | 261.12 Million USD | 51.999% |
Sanara MedTech Inc. | 61.12 Million USD | -105.051% |
STAAR Surgical Company | 224.55 Million USD | 44.182% |
Sharps Technology, Inc. | 10.12 Million USD | -1137.744% |
Utah Medical Products, Inc. | 13.26 Million USD | -845.193% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 93.013% |
Jin Medical International Ltd. | 3.91 Million USD | -3099.482% |